In adult patients with hematological malignancies with bacterial infection of the lungs, as an anti-inflammatory factor, the increase of IL-10 may be to inhibit the high expression of the pro-inflammatory factors IL-6 and IL-8. This evidence concerns the gene IL6 and hematologic disorder.